Neumora Therapeutics (NMRA) Other Non-Current Assets (2022 - 2026)

Neumora Therapeutics has reported Other Non-Current Assets for 5 years, with the latest figure at $53000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 95.63% year-over-year to $53000.0; the trailing twelve-month figure through Mar 2026 stood at $53000.0 (down 95.63% YoY), and the FY2025 full-year result was $53000.0, down 95.63% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $53000.0, roughly flat from $53000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.3 million in Q4 2022, with the low at $53000.0 in Q4 2025.
• Average Other Non-Current Assets over 5 years is $936066.7, with a median of $1.2 million recorded in 2023.
• Year-over-year, Other Non-Current Assets changed 0.0% in 2024 and slumped 95.63% in 2025.
• Tracing NMRA's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then decreased by 3.96% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then tumbled by 95.63% to $53000.0 in 2025, then changed by 0.0% to $53000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $53000.0 (Q1 2026), $53000.0 (Q4 2025), and $197000.0 (Q3 2025), per Business Quant data.

Peer Comparison